These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 2006528
1. Prolonged survival of rat cardiac allografts by donor pretreatment with methotrexate. Enhancement by combined immunosuppressant treatment of the recipient. Kahn DR, Forrest DE, Otto DA. Transplantation; 1991 Mar; 51(3):697-700. PubMed ID: 2006528 [Abstract] [Full Text] [Related]
2. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E. Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767 [Abstract] [Full Text] [Related]
4. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Cramer DV, Chapman FA, Jaffee BD, Jones EA, Knoop M, Hreha-Eiras G, Makowka L. Transplantation; 1992 Feb 18; 53(2):303-8. PubMed ID: 1531394 [Abstract] [Full Text] [Related]
5. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K. Transplantation; 1987 Dec 18; 44(6):734-8. PubMed ID: 2447689 [Abstract] [Full Text] [Related]
9. Improved survival of heterotopic cardiac allografts in rats with dietary n-3 polyunsaturated fatty acids. Otto DA, Kahn DR, Hamm MW, Forrest DE, Wooten JT. Transplantation; 1990 Aug 18; 50(2):193-8. PubMed ID: 2382285 [Abstract] [Full Text] [Related]
14. Bromocriptine plus suboptimal cyclosporine treatment abrogates acute rejection of rat cardiac allografts. Di Stefano R, Carmellini M, Carobbi A, Vaglini F, Petrini M, Ricci F, Mosca F, Malvaldi G. Transplant Proc; 1990 Aug 18; 22(4):2015-6. PubMed ID: 2389514 [No Abstract] [Full Text] [Related]
15. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage. Tchervenkov JI, Cofer BR, Davies C, Alexander JW. Transplantation; 1995 Mar 27; 59(6):821-4. PubMed ID: 7701575 [Abstract] [Full Text] [Related]
17. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts. Oluwole SF, Tezuka K, Wasfie T, Stegall MD, Reemtsma K, Hardy MA. Transplantation; 1989 Nov 27; 48(5):751-5. PubMed ID: 2815247 [Abstract] [Full Text] [Related]
18. The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival. Tchervenkov JI, Epstein MD, Alexander JW, Schroeder TJ. Transplantation; 1989 Jan 27; 47(1):177-81. PubMed ID: 2643225 [Abstract] [Full Text] [Related]
19. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine. Oluwole SF, Fawwaz RA, Reemtsma K, Hardy MA. Transplantation; 1988 Jun 27; 45(6):1131-5. PubMed ID: 3289153 [Abstract] [Full Text] [Related]
20. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection. Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A. Transplantation; 2002 Jun 15; 73(11):1736-42. PubMed ID: 12084995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]